Neuroendocrine Tumors

Neuroendocrine Tumors are uncommon tumors that begin in neuroendocrine cells, which have features of both nerve cells and hormone-producing cells. They can develop in many organs, grow slowly or aggressively, and may or may not release hormones that cause noticeable symptoms.

Overview

Neuroendocrine Tumors, often shortened to NETs, are tumors that start in neuroendocrine cells. These cells receive signals from the nervous system and can release hormones into the blood. Because neuroendocrine cells are found throughout the body, NETs can begin in different organs, most commonly the gastrointestinal tract, pancreas and lungs.

Neuroendocrine Tumors are a diverse group of diseases rather than one single condition. Some are slow-growing and found incidentally during tests for another problem. Others grow more quickly or spread to nearby lymph nodes, the liver, bones or other organs. A key part of diagnosis is determining the tumor’s location, grade and stage, because these details guide treatment.

Some NETs are called functional tumors because they release hormones that cause symptoms. Others are non-functional and do not produce enough hormones to cause a clear syndrome. Older terms such as carcinoid tumor may still be used, especially for certain gastrointestinal or lung NETs, but modern care usually classifies them more precisely by organ of origin and tumor biology.

Symptoms

Neuroendocrine Tumors symptoms vary widely. A small, slow-growing NET may not cause symptoms for years. When symptoms do occur, they may be related to the tumor’s size and location, to hormone production, or to spread of the disease.

Possible symptoms include ongoing abdominal pain, bloating, nausea, vomiting, changes in bowel habits, unexplained weight loss, fatigue, cough, wheezing, chest discomfort or blood in the stool. Pancreatic NETs may cause symptoms related to changes in insulin, gastrin or other hormone levels, such as episodes of low blood sugar, stomach ulcers, diarrhea or skin changes.

Some people develop a hormone-related pattern called carcinoid syndrome, most often when certain NETs have spread to the liver. Symptoms may include facial flushing, diarrhea, wheezing, a fast heartbeat or, over time, heart valve problems. These symptoms can also have many non-cancer causes, so a specialist assessment is important for an accurate diagnosis.

Causes & Risk Factors

The exact cause of most Neuroendocrine Tumors is not known. Like other tumors, NETs develop when cells acquire changes that allow them to grow in an uncontrolled way. These changes are usually not inherited and may occur over time, but in a minority of people, NETs are linked to inherited genetic syndromes.

Risk factors can differ depending on where the tumor begins. Some pancreatic and other endocrine NETs are associated with genetic conditions such as multiple endocrine neoplasia type 1, von Hippel-Lindau disease, neurofibromatosis type 1 or tuberous sclerosis complex. Having one of these conditions does not mean a person will definitely develop a NET, but it may justify specialist surveillance.

Other factors sometimes associated with NET risk include age, family history of certain endocrine tumors and long-standing conditions affecting the stomach in selected cases. However, many people diagnosed with a NET have no clear risk factor. For this reason, symptoms that persist or are unexplained should be discussed with a qualified doctor rather than attributed to lifestyle alone.

Diagnosis

Diagnosis of Neuroendocrine Tumors usually starts with a medical history, physical examination and review of symptoms. The doctor may ask about flushing, diarrhea, breathing symptoms, blood sugar episodes, stomach ulcer symptoms, weight changes and family history. Because NETs can mimic more common conditions, diagnosis may require several steps.

Blood and urine tests may be used to look for hormone activity or tumor markers, depending on the suspected NET type. Imaging tests help locate the tumor and check whether it has spread. These may include ultrasound, CT, MRI, specialized nuclear medicine scans, or PET imaging designed to detect somatostatin receptors on many NET cells.

Endoscopy, colonoscopy, bronchoscopy or endoscopic ultrasound may be recommended when the suspected tumor is in the digestive tract, pancreas or lungs. A biopsy is often needed to confirm the diagnosis. Pathology testing identifies neuroendocrine features and assesses the grade, often using markers of cell growth. Grade and stage are essential because they help the specialist team estimate behavior and choose the most appropriate treatment approach.

Treatment Options

Neuroendocrine Tumors treatment is individualized. The right approach depends on the tumor’s organ of origin, size, grade, stage, hormone activity, symptoms, imaging findings and the person’s general health. Decisions are usually made by a multidisciplinary team that may include medical oncology, surgery, gastroenterology, endocrinology, nuclear medicine, radiology, pathology and supportive care specialists.

Surgery may be recommended when the tumor can be safely removed, especially for localized disease. In selected cases, surgery may also help control symptoms or reduce tumor burden even when disease has spread. For tumors that produce hormones, medications may be used to reduce hormone-related symptoms and may help control tumor growth in some patients.

Other treatment categories can include targeted therapies, peptide receptor radionuclide therapy when the tumor has appropriate receptor expression, chemotherapy for selected higher-grade or pancreatic NETs, radiotherapy for symptom control in certain sites, and liver-directed treatments when the liver is a major area of disease. Supportive treatments may address nutrition, diarrhea, pain, fatigue, emotional health and complications related to hormone excess.

Because NETs differ so much from person to person, no single treatment plan fits everyone. A specialist should explain the goals of treatment, which may be cure, long-term control, symptom relief or prevention of complications. International patients may seek coordinated assessment in centers such as Acibadem International, where multidisciplinary specialists in JCI-accredited hospitals diagnose and treat Neuroendocrine Tumors.

Living With / Prognosis

The prognosis for Neuroendocrine Tumors depends on several factors, including where the tumor started, whether it has spread, how quickly the cells are dividing, whether hormones are causing symptoms and how well the tumor responds to treatment. Many NETs grow slowly and can be managed over a long period with monitoring and treatment when needed. Others require more active or combined treatment.

Living with a NET often involves regular follow-up. Follow-up may include symptom review, physical examination, blood or urine tests and imaging at intervals chosen by the care team. Patients should keep a record of new symptoms, treatment side effects and any episodes such as flushing, diarrhea, wheezing or low blood sugar, because these details can help guide care.

Healthy routines can support overall wellbeing but do not replace medical treatment. A balanced diet, appropriate physical activity, adequate sleep and support for stress or anxiety may help patients cope better. Some people benefit from dietitian input, especially if they have bowel symptoms, pancreatic surgery, weight loss or hormone-related digestive changes.

When to See a Doctor

A doctor should be consulted for persistent or unexplained symptoms such as ongoing abdominal pain, recurrent diarrhea, flushing, wheezing, unexplained weight loss, repeated stomach ulcers, changes in blood sugar, blood in the stool or a cough that does not improve. These symptoms are more often caused by conditions other than Neuroendocrine Tumors, but medical evaluation helps identify the cause and start appropriate care.

People with a known NET should contact their care team if symptoms worsen, new symptoms appear, or treatment side effects interfere with daily life. Urgent medical advice is needed for severe dehydration, fainting, severe breathing difficulty, chest pain, confusion, severe abdominal pain or symptoms of very low blood sugar.

Anyone with an inherited syndrome linked to NETs, or a strong family history of endocrine tumors, should ask a specialist whether genetic counseling or surveillance is appropriate. Early and accurate assessment can help clarify risk and support timely care without unnecessary worry.

Frequently asked questions

What are Neuroendocrine Tumors?

Neuroendocrine Tumors are tumors that develop from neuroendocrine cells, which can respond to nerve signals and release hormones. They can occur in many parts of the body, especially the digestive system, pancreas and lungs. Some grow slowly, while others behave more aggressively.

Are Neuroendocrine Tumors cancer?

Many Neuroendocrine Tumors are considered cancers because they can grow, invade nearby tissue or spread to other organs. However, their behavior varies greatly. A specialist uses the tumor grade, stage and site to understand how it is likely to behave.

What are the most common Neuroendocrine Tumors symptoms?

Symptoms may include abdominal pain, diarrhea, flushing, wheezing, cough, nausea, weight loss, fatigue or changes in blood sugar. Some people have no symptoms and the tumor is found during imaging or endoscopy for another reason. Symptoms depend on the tumor’s location and whether it releases hormones.

How are Neuroendocrine Tumors diagnosed?

Diagnosis may include blood and urine tests, CT or MRI scans, specialized nuclear medicine imaging, endoscopy and biopsy. The biopsy is examined by a pathologist to confirm neuroendocrine features and measure how fast the tumor cells are growing. These results guide treatment planning.

Can Neuroendocrine Tumors be cured?

Some localized Neuroendocrine Tumors can be cured with surgery if they are completely removed. If the tumor has spread, treatment may still control growth and symptoms for a long time in selected patients. The outlook depends on the tumor type, grade, stage and response to treatment.

What treatments are used for Neuroendocrine Tumors?

Treatment may include surgery, medicines to control hormones, targeted therapies, peptide receptor radionuclide therapy, chemotherapy, radiotherapy, liver-directed procedures and supportive care. Not every patient needs every treatment. The best approach is chosen by a specialist team after a full assessment.

Do Neuroendocrine Tumors require long-term follow-up?

Yes, follow-up is usually important because some NETs can recur, grow slowly over time or cause hormone-related complications. Follow-up schedules vary depending on the tumor type and treatment received. Patients should keep appointments and report new or changing symptoms to their care team.

References

• World Health Organization
• European Society for Medical Oncology
• National Cancer Institute
• North American Neuroendocrine Tumor Society
• European Neuroendocrine Tumor Society

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.